Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Blood
|
December 12, 2025
Orca-T versus allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trial
Everett Meyer, Amandeep Salhotra, Arpita Gandhi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 3, 2018
ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors
Shahrukh K Hashmi, Stephanie J Lee, Bipin N Savani, et al.
Blood Advances
|
March 18, 2024
CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity
Mark P Hamilton, Erin Craig, Cesar Gentille Sanchez, et al.
Blood
|
January 29, 2021
CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR-refractory large B-cell lymphoma
John H Baird, Matthew J Frank, Juliana Craig, et al.
Leukemia
|
March 16, 2024
CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results
Liora M Schultz, Nikeshan Jeyakumar, Anne Marijn Kramer, et al.
Research Square
|
November 24, 2025
CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias
Mark P Hamilton, Nick Phillips, Troy Noordenbos, et al.
Science (New York, N.Y.)
|
February 20, 2025
Disease diagnostics using machine learning of B cell and T cell receptor sequences
Maxim E Zaslavsky, Erin Craig, Jackson K Michuda, et al.
Biorxiv : the Preprint Server for Biology
|
May 13, 2022
Disease diagnostics using machine learning of immune receptors
Maxim E Zaslavsky, Erin Craig, Jackson K Michuda, et al.
Nature Medicine
|
July 27, 2021
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
Jay Y Spiegel, Shabnum Patel, Lori Muffly, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Blood
|
December 12, 2025
Orca-T versus allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trial
Everett Meyer, Amandeep Salhotra, Arpita Gandhi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 3, 2018
ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors
Shahrukh K Hashmi, Stephanie J Lee, Bipin N Savani, et al.
Blood Advances
|
March 18, 2024
CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity
Mark P Hamilton, Erin Craig, Cesar Gentille Sanchez, et al.
Blood
|
January 29, 2021
CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR-refractory large B-cell lymphoma
John H Baird, Matthew J Frank, Juliana Craig, et al.
Leukemia
|
March 16, 2024
CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results
Liora M Schultz, Nikeshan Jeyakumar, Anne Marijn Kramer, et al.
Research Square
|
November 24, 2025
CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias
Mark P Hamilton, Nick Phillips, Troy Noordenbos, et al.
Science (New York, N.Y.)
|
February 20, 2025
Disease diagnostics using machine learning of B cell and T cell receptor sequences
Maxim E Zaslavsky, Erin Craig, Jackson K Michuda, et al.
Biorxiv : the Preprint Server for Biology
|
May 13, 2022
Disease diagnostics using machine learning of immune receptors
Maxim E Zaslavsky, Erin Craig, Jackson K Michuda, et al.
Nature Medicine
|
July 27, 2021
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
Jay Y Spiegel, Shabnum Patel, Lori Muffly, et al.
Page
of 5